Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Express Scripts
Cerilliant
McKinsey
Colorcon
Medtronic
Harvard Business School
Accenture
Federal Trade Commission

Generated: October 18, 2018

DrugPatentWatch Database Preview

Fresenius Kabi Oncol Company Profile

« Back to Dashboard

What is the competitive landscape for FRESENIUS KABI ONCOL, and what generic and branded alternatives to FRESENIUS KABI ONCOL drugs are available?

FRESENIUS KABI ONCOL has twelve approved drugs.



Summary for Fresenius Kabi Oncol

Drugs and US Patents for Fresenius Kabi Oncol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Oncol MITOXANTRONE HYDROCHLORIDE mitoxantrone hydrochloride INJECTABLE;INJECTION 078606-003 May 14, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Oncol MITOXANTRONE HYDROCHLORIDE mitoxantrone hydrochloride INJECTABLE;INJECTION 078606-001 May 14, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Oncol CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077432-003 Sep 29, 2006 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
AstraZeneca
Baxter
Federal Trade Commission
US Department of Justice
Medtronic
Boehringer Ingelheim
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.